- Home
- CRBP vs CGTL Comparison
CRBP vs CGTL Comparison
Compare CRBP & CGTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- CGTL
- Stock Information
- Founded
- CRBP 2009
- CGTL 2016
- Country
- CRBP United States
- CGTL Hong Kong
- Employees
- CRBP N/A
- CGTL N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- CGTL
- Sector
- CRBP Health Care
- CGTL
- Exchange
- CRBP Nasdaq
- CGTL NYSE
- Market Cap
- CRBP 73.4M
- CGTL 70.3M
- IPO Year
- CRBP N/A
- CGTL 2024
- Fundamental
- Price
- CRBP $5.31
- CGTL $4.30
- Analyst Decision
- CRBP Strong Buy
- CGTL
- Analyst Count
- CRBP 10
- CGTL 0
- Target Price
- CRBP $60.89
- CGTL N/A
- AVG Volume (30 Days)
- CRBP 213.2K
- CGTL 65.4K
- Earning Date
- CRBP 03-11-2025
- CGTL 05-15-2025
- Dividend Yield
- CRBP N/A
- CGTL N/A
- EPS Growth
- CRBP N/A
- CGTL 35.72
- EPS
- CRBP N/A
- CGTL 0.21
- Revenue
- CRBP N/A
- CGTL $35,611,761.00
- Revenue This Year
- CRBP N/A
- CGTL N/A
- Revenue Next Year
- CRBP $270.01
- CGTL N/A
- P/E Ratio
- CRBP N/A
- CGTL $19.71
- Revenue Growth
- CRBP N/A
- CGTL N/A
- 52 Week Low
- CRBP $5.12
- CGTL $2.80
- 52 Week High
- CRBP $61.90
- CGTL $10.59
- Technical
- Relative Strength Index (RSI)
- CRBP 27.45
- CGTL N/A
- Support Level
- CRBP $5.76
- CGTL N/A
- Resistance Level
- CRBP $6.17
- CGTL N/A
- Average True Range (ATR)
- CRBP 0.39
- CGTL 0.00
- MACD
- CRBP 0.03
- CGTL 0.00
- Stochastic Oscillator
- CRBP 9.73
- CGTL 0.00
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About CGTL CREATIVE GLOBAL TECHNOLOGY HOLDINGS LIMITED
Creative Global Technology Holdings Ltd conducts its business through its subsidiary, which is a Hong Kong-based company sourcing and reselling recycled consumer electronic devices, currently mostly smartphones, tablets, and laptops.